JPH107552A5 - - Google Patents

Info

Publication number
JPH107552A5
JPH107552A5 JP1997060781A JP6078197A JPH107552A5 JP H107552 A5 JPH107552 A5 JP H107552A5 JP 1997060781 A JP1997060781 A JP 1997060781A JP 6078197 A JP6078197 A JP 6078197A JP H107552 A5 JPH107552 A5 JP H107552A5
Authority
JP
Japan
Prior art keywords
weight
sustained
release formulation
venlafaxine hydrochloride
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997060781A
Other languages
English (en)
Japanese (ja)
Other versions
JP4771565B2 (ja
JPH107552A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH107552A publication Critical patent/JPH107552A/ja
Publication of JPH107552A5 publication Critical patent/JPH107552A5/ja
Application granted granted Critical
Publication of JP4771565B2 publication Critical patent/JP4771565B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP06078197A 1996-03-25 1997-03-14 持続放出性製剤 Expired - Fee Related JP4771565B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1400696P 1996-03-25 1996-03-25
US60/014006 1996-03-25

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008064149A Division JP2008156374A (ja) 1996-03-25 2008-03-13 持続放出性製剤

Publications (3)

Publication Number Publication Date
JPH107552A JPH107552A (ja) 1998-01-13
JPH107552A5 true JPH107552A5 (enExample) 2004-12-24
JP4771565B2 JP4771565B2 (ja) 2011-09-14

Family

ID=21762972

Family Applications (2)

Application Number Title Priority Date Filing Date
JP06078197A Expired - Fee Related JP4771565B2 (ja) 1996-03-25 1997-03-14 持続放出性製剤
JP2008064149A Pending JP2008156374A (ja) 1996-03-25 2008-03-13 持続放出性製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008064149A Pending JP2008156374A (ja) 1996-03-25 2008-03-13 持続放出性製剤

Country Status (33)

Country Link
EP (2) EP0797991B1 (enExample)
JP (2) JP4771565B2 (enExample)
KR (1) KR101096512B1 (enExample)
CN (2) CN1090018C (enExample)
AR (1) AR006519A1 (enExample)
AT (1) ATE257011T1 (enExample)
AU (1) AU727653B2 (enExample)
BR (1) BR9701304A (enExample)
CA (1) CA2199778C (enExample)
CO (1) CO4761054A1 (enExample)
CY (1) CY2442B1 (enExample)
CZ (1) CZ291637B6 (enExample)
DE (1) DE69727000T2 (enExample)
DK (1) DK0797991T3 (enExample)
EG (1) EG24198A (enExample)
ES (1) ES2210454T3 (enExample)
HU (1) HU224617B1 (enExample)
IL (1) IL120382A (enExample)
IN (1) IN187337B (enExample)
NO (2) NO320355B1 (enExample)
NZ (1) NZ314442A (enExample)
PA (1) PA8426401A1 (enExample)
PE (1) PE57198A1 (enExample)
PL (2) PL188444B1 (enExample)
PT (1) PT797991E (enExample)
RU (1) RU2176912C2 (enExample)
SK (1) SK281530B6 (enExample)
SV (1) SV1997000015A (enExample)
TR (1) TR199700190A2 (enExample)
TW (1) TW493993B (enExample)
UA (1) UA44904C2 (enExample)
UY (1) UY24613A1 (enExample)
ZA (1) ZA972403B (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
JP3379461B2 (ja) * 1998-08-06 2003-02-24 三菱電機株式会社 コア部材の積層金型装置、コア部材の積層方法および電動機
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
SK286865B6 (sk) * 1999-05-20 2009-06-05 Elan Pharma International Limited Multičasticový farmaceutický prostriedok s riadeným uvoľňovaním selektívneho inhibítora spätného príjmu serotonínu a jeho použitie
ES2162746B1 (es) * 1999-10-21 2003-02-16 Lipotec Sa Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
GB0025208D0 (en) * 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
CA2426158A1 (en) * 2000-10-19 2002-06-13 Teva Pharmaceutical Industries Ltd. Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
US6717015B2 (en) 2002-03-28 2004-04-06 Synthon Bv Venlafaxine besylate
WO2003082261A1 (en) * 2002-03-28 2003-10-09 Synthon B.V. Extended release venlafaxine formulations
AU2003226751A1 (en) 2002-03-28 2003-10-13 Synthon B.V. Low water-soluble venlafaxine salts
EP1596837A2 (en) * 2003-02-07 2005-11-23 Omega Farma Ehf Sustained release formulations of venlafaxine
TW200503670A (en) * 2003-03-28 2005-02-01 Sandoz Ag Venlafaxine compositions
ATE344659T1 (de) * 2003-05-02 2006-11-15 Dexcel Ltd Tablettenzubereitung mit verlängerter freisetzung von venlafaxin
IN2003MU00504A (enExample) * 2003-06-05 2005-05-13 Alembic Ltd
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
SI1502587T1 (sl) 2003-07-30 2007-02-28 Pharmathen Sa Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid
WO2005048979A2 (en) * 2003-10-06 2005-06-02 Torrent Pharmaceuticals Limited Pharmaceutical composition having casing with multiple micro tablets
HUP0303382A2 (hu) * 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
EP1523979A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release pharmaceutical dosage form
EP1523981A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release formulations of venlafaxine
DE10359154A1 (de) 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
DK1711169T3 (da) 2004-02-04 2007-09-17 Alembic Ltd Coatede mikrodepottabletter med venlafaxinhydrochlorid
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US7776358B2 (en) 2004-07-22 2010-08-17 Synthon Ip Inc. Extended release venlafaxine besylate tablets
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
CN100463676C (zh) * 2004-11-11 2009-02-25 成都康弘药业集团股份有限公司 一种盐酸文拉法辛控释片制剂及其制备方法
ITFI20050206A1 (it) * 2005-09-30 2007-04-01 Valpharma Sa Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
JP5457830B2 (ja) * 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
CA2648495C (en) 2006-04-26 2016-07-05 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
KR100791194B1 (ko) * 2006-06-12 2008-01-02 코오롱제약주식회사 염산 벤라팍신의 경구 투여용 서방성 펠렛 및 그 제조방법
KR101791715B1 (ko) * 2010-02-03 2017-10-30 파마 투 비 엘티디 라사길린의 연장 방출 제형 및 그 용도
WO2011132008A2 (en) 2010-04-22 2011-10-27 EGIS Gyűgyszergyár Nyilvánosan Múködő Részvény társaság Controlled release pharmaceutical composition
CA2826180C (en) 2011-01-31 2020-09-01 Serotech, Llc Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
CN103893151B (zh) * 2012-12-31 2018-04-27 石药集团中奇制药技术（石家庄）有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
EP3624788A4 (en) 2017-05-17 2021-03-03 Confluence Pharmaceuticals, LLC FORMULATIONS OF HOMOTAURINS AND THEIR SALTS
CN114288273B (zh) * 2022-02-11 2022-10-18 桂林华信制药有限公司 一种盐酸文拉法辛缓释胶囊及其生产工艺
JP2023127913A (ja) * 2022-03-02 2023-09-14 共和薬品工業株式会社 ベンラファキシン塩酸塩含有顆粒
JP2025120141A (ja) 2024-02-03 2025-08-15 共和薬品工業株式会社 ベンラファキシン塩酸塩含有徐放性顆粒の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4535186A (en) 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
IE56324B1 (en) * 1982-12-13 1991-06-19 American Home Prod Phenethylamine derivatives and intermediates therefor
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
IE60311B1 (en) 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ATE342715T1 (de) * 1993-06-28 2006-11-15 Wyeth Corp Neue behandlungsmethoden durch verwendung von phenethylderivaten
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada

Similar Documents

Publication Publication Date Title
JPH107552A5 (enExample)
CA1282698C (en) Time controlled explosion systems and processes for preparing the same
JP2007511510A (ja) 持続放出性ベンラファキシン製剤
KR970064599A (ko) 서방성 제형
CA2038245C (en) Pharmaceutically useful micropellets
JP4369752B2 (ja) プロプラノロールの時限徐放性多粒子剤型
AU2005247019B2 (en) Multiparticulate modified release composition
EP1465608B1 (en) Extended release compositions comprising as active compound venlafaxine hydrochloride
RU97103563A (ru) Композиции длительного высвобождения венлафаксин гидрохлорида, композиция пленочного покрытия, способ обеспечения терапевтически активной концентрации венлафаксина и способ исключения нулевых и пиковых концентраций лекарственного средства
EP1123700B1 (en) Timed pulsatile drug delivery systems
US20040047906A1 (en) Timed, sustained release systems for propranolol
IE59200B1 (en) Therapeutic compositions for oral administration
ATE239454T1 (de) Orale morphinzubereitung in teilchenform
NZ200519A (en) Sustained release pellet containing indoramin
JPH04217918A (ja) 一日一回投与のための吸収の制御されたナプロキセン配合物
MY148475A (en) Controlled release preparations comprising tramadol and topiramate
US10213389B2 (en) Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
JPH0662405B2 (ja) Ｌ―ドーパ含有組成物
AU2005279329A1 (en) Pharmaceutical multiparticulate compositions comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin
CA2068980A1 (en) Diltiazem formulation
JP2004532828A5 (enExample)
WO1999042087A3 (en) Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content
CA2433915A1 (en) Improved controlled release oral dosage form
JP2002512946A5 (enExample)
CN112891322A (zh) 右旋布洛芬制剂及其制备方法